Etubics Corporation is a clinical stage biotechnology company focused on developing immunotherapeutics for the treatment of cancer and vaccines against infectious diseases. The Company has a pipeline of product candidates based on our proprietary, advanced generation viral vector platform the Etubics Platform to generate both T cell mediated and antibody responses and its complimentary manufacturing human-based cell line.